JEFFERSON BOULET: Open Payments
NPI 1740274745 · BUCKLEY, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$707 in 37 payments from 14 companies in 2025. Trend: 2023 $87 · 2024 $336 · 2025 $707
Food & beverage: $707
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 11 | $206 |
| Otsuka America Pharmaceutical, Inc. | 12 | $185 |
| Phathom Pharmaceuticals, Inc. | 3 | $34 |
| Antares Pharma, Inc. | 1 | $32 |
| Lilly USA, LLC | 1 | $32 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $31 |
| Astellas Pharma US Inc | 1 | $28 |
| Sumitomo Pharma America, Inc. | 1 | $26 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $26 |
| Teva Pharmaceuticals USA, Inc. | 1 | $23 |
Products named: REXULTI, UBRELVY, VRAYLAR, QULIPTA, VOQUEZNA, XYOSTED, JARDIANCE, Kerendia.
Industry payments across WA — which companies pay providers there.
